⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Johnson & Johnson unveils new data showing nipocalimab is the first and only investigational FcRn blocker with potential to reduce systemic lupus erythematosus (SLE) activity in a Phase 2 study
prnewswire.com
JNJ
Fresenius Kabi Introduces New Presentation of Otulfi ® (ustekinumab-aauz), a Biosimilar to Stelara ®
businesswire.com
JNJ
FMS
Johnson & Johnson submits application to the European Medicines Agency for TECVAYLI®▼ (teclistamab) in combination with DARZALEX® (daratumumab) subcutaneous formulation for patients with relapsed/refractory multiple myeloma
globenewswire.com
JNJ
Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report USA - English India - English
prnewswire.com
CLVT
LLY
GSK
JNJ
SNY
CELC
CRBP
BMY
Castration-sensitive Prostate Cancer Market Projected to Grow at a 13.2% CAGR (2020-2034), Driven by Expanded Approval and Wider Commercialization Opportunity in nmCSPC Segment | DelveInsight
prnewswire.com
AZN
JNJ
PFE
ORGN
Marquis Who's Who Honors Marina Derosa as a Leader in Business Management
accessnewswire.com
JNJ
MRK
BP
Legal Bay Settlement Funding Reports Johnson & Johnson Hit with Almost $1 Billion in Trial Damages During Fourth Quarter of 2025
prnewswire.com
JNJ
Trends & Strategies Shaping the $7.5 Billion Sex Reassignment Surgery Market, 2025-2033
globenewswire.com
JNJ
The Connectivity Standards Alliance Announces Unify, Its Inaugural Event to Define the Future of Connectivity and Interoperability
prnewswire.com
SLAB
NXPI
AMZN
GOOG
AAPL
INTC
MSFT
NVDA
QCOM
AMBA
ON
TER
ADI
TXN
STM
CMCSA
FOR
LEG
NOC
RTO
SU
SM
TUYA
VZ
ESPR
ALGN
BRK.A
JNJ
V
PG
MA
KO
PEP
DIS
HD
CHTR
T
CSCO
IBM
CRM
ACN
ORCL
HPQ
DELL
MSI
MRVL
AMD
MU
WDC
STX
LRCX
KLAC
ASML
AMAT
MCHP
AVGO
ADSK
CDNS
SNPS
MPWR
RMBS
QRVO
SWKS
CivicaScript announces availability of low-cost insulin and biosimilar for chronic inflammatory conditions in the US
prnewswire.com
JNJ